United States Human Rotavirus Vaccine Market Report 2018

January 2018 | 99 pages | ID: UEE21EE857CEN
QYResearch

Abstracts

In this report, the United States Human Rotavirus Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Human Rotavirus Vaccine in these regions, from 2012 to 2022 (forecast).

United States Human Rotavirus Vaccine market competition by top manufacturers/players, with Human Rotavirus Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Merck & Co., Inc.
• Bharat Biotech
• GlaxoSmithKline plc.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Rotarix
• RotaTeq
• Rotavac
• Rotavin-M1
• Lanzhou lamb

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospitals
• Clinics
• Academic and Research
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Human Rotavirus Vaccine Market Report 2017

1 HUMAN ROTAVIRUS VACCINE OVERVIEW

1.1 Product Overview and Scope of Human Rotavirus Vaccine
1.2 Classification of Human Rotavirus Vaccine by Product Category
  1.2.1 United States Human Rotavirus Vaccine Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Human Rotavirus Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Rotarix
  1.2.4 RotaTeq
  1.2.5 Rotavac
  1.2.6 Rotavin-M1
  1.2.7 Lanzhou lamb
1.3 United States Human Rotavirus Vaccine Market by Application/End Users
  1.3.1 United States Human Rotavirus Vaccine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Academic and Research
  1.3.5 Others
1.4 United States Human Rotavirus Vaccine Market by Region
  1.4.1 United States Human Rotavirus Vaccine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Human Rotavirus Vaccine Status and Prospect (2012-2022)
  1.4.3 Southwest Human Rotavirus Vaccine Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Human Rotavirus Vaccine Status and Prospect (2012-2022)
  1.4.5 New England Human Rotavirus Vaccine Status and Prospect (2012-2022)
  1.4.6 The South Human Rotavirus Vaccine Status and Prospect (2012-2022)
  1.4.7 The Midwest Human Rotavirus Vaccine Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Human Rotavirus Vaccine (2012-2022)
  1.5.1 United States Human Rotavirus Vaccine Sales and Growth Rate (2012-2022)
  1.5.2 United States Human Rotavirus Vaccine Revenue and Growth Rate (2012-2022)

2 UNITED STATES HUMAN ROTAVIRUS VACCINE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Human Rotavirus Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Human Rotavirus Vaccine Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Human Rotavirus Vaccine Average Price by Players/Suppliers (2012-2017)
2.4 United States Human Rotavirus Vaccine Market Competitive Situation and Trends
  2.4.1 United States Human Rotavirus Vaccine Market Concentration Rate
  2.4.2 United States Human Rotavirus Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Human Rotavirus Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES HUMAN ROTAVIRUS VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Human Rotavirus Vaccine Sales and Market Share by Region (2012-2017)
3.2 United States Human Rotavirus Vaccine Revenue and Market Share by Region (2012-2017)
3.3 United States Human Rotavirus Vaccine Price by Region (2012-2017)

4 UNITED STATES HUMAN ROTAVIRUS VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Human Rotavirus Vaccine Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Human Rotavirus Vaccine Revenue and Market Share by Type (2012-2017)
4.3 United States Human Rotavirus Vaccine Price by Type (2012-2017)
4.4 United States Human Rotavirus Vaccine Sales Growth Rate by Type (2012-2017)

5 UNITED STATES HUMAN ROTAVIRUS VACCINE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Human Rotavirus Vaccine Sales and Market Share by Application (2012-2017)
5.2 United States Human Rotavirus Vaccine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES HUMAN ROTAVIRUS VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Merck & Co., Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Human Rotavirus Vaccine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Merck & Co., Inc. Human Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bharat Biotech
  6.2.2 Human Rotavirus Vaccine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bharat Biotech Human Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 GlaxoSmithKline plc.
  6.3.2 Human Rotavirus Vaccine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 GlaxoSmithKline plc. Human Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview

7 HUMAN ROTAVIRUS VACCINE MANUFACTURING COST ANALYSIS

7.1 Human Rotavirus Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Human Rotavirus Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Human Rotavirus Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Human Rotavirus Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HUMAN ROTAVIRUS VACCINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Human Rotavirus Vaccine Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Human Rotavirus Vaccine Sales Volume Forecast by Type (2017-2022)
11.3 United States Human Rotavirus Vaccine Sales Volume Forecast by Application (2017-2022)
11.4 United States Human Rotavirus Vaccine Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Human Rotavirus Vaccine
Figure United States Human Rotavirus Vaccine Market Size (K MT) by Type (2012-2022)
Figure United States Human Rotavirus Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Rotarix Product Picture
Figure RotaTeq Product Picture
Figure Rotavac Product Picture
Figure Rotavin-M1 Product Picture
Figure Lanzhou lamb Product Picture
Figure United States Human Rotavirus Vaccine Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Human Rotavirus Vaccine by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Academic and Research Examples
Table Key Downstream Customer in Academic and Research
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Human Rotavirus Vaccine Market Size (Million USD) by Region (2012-2022)
Figure The West Human Rotavirus Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Human Rotavirus Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Human Rotavirus Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Human Rotavirus Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Human Rotavirus Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Human Rotavirus Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Human Rotavirus Vaccine Sales (K MT) and Growth Rate (2012-2022)
Figure United States Human Rotavirus Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Human Rotavirus Vaccine Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Human Rotavirus Vaccine Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Human Rotavirus Vaccine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Human Rotavirus Vaccine Sales Share by Players/Suppliers
Figure 2017 United States Human Rotavirus Vaccine Sales Share by Players/Suppliers
Figure United States Human Rotavirus Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Human Rotavirus Vaccine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Human Rotavirus Vaccine Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Human Rotavirus Vaccine Revenue Share by Players/Suppliers
Figure 2017 United States Human Rotavirus Vaccine Revenue Share by Players/Suppliers
Table United States Market Human Rotavirus Vaccine Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Human Rotavirus Vaccine Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Human Rotavirus Vaccine Market Share of Top 3 Players/Suppliers
Figure United States Human Rotavirus Vaccine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Human Rotavirus Vaccine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Human Rotavirus Vaccine Product Category
Table United States Human Rotavirus Vaccine Sales (K MT) by Region (2012-2017)
Table United States Human Rotavirus Vaccine Sales Share by Region (2012-2017)
Figure United States Human Rotavirus Vaccine Sales Share by Region (2012-2017)
Figure United States Human Rotavirus Vaccine Sales Market Share by Region in 2016
Table United States Human Rotavirus Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Human Rotavirus Vaccine Revenue Share by Region (2012-2017)
Figure United States Human Rotavirus Vaccine Revenue Market Share by Region (2012-2017)
Figure United States Human Rotavirus Vaccine Revenue Market Share by Region in 2016
Table United States Human Rotavirus Vaccine Price (USD/MT) by Region (2012-2017)
Table United States Human Rotavirus Vaccine Sales (K MT) by Type (2012-2017)
Table United States Human Rotavirus Vaccine Sales Share by Type (2012-2017)
Figure United States Human Rotavirus Vaccine Sales Share by Type (2012-2017)
Figure United States Human Rotavirus Vaccine Sales Market Share by Type in 2016
Table United States Human Rotavirus Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Human Rotavirus Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Human Rotavirus Vaccine by Type (2012-2017)
Figure Revenue Market Share of Human Rotavirus Vaccine by Type in 2016
Table United States Human Rotavirus Vaccine Price (USD/MT) by Types (2012-2017)
Figure United States Human Rotavirus Vaccine Sales Growth Rate by Type (2012-2017)
Table United States Human Rotavirus Vaccine Sales (K MT) by Application (2012-2017)
Table United States Human Rotavirus Vaccine Sales Market Share by Application (2012-2017)
Figure United States Human Rotavirus Vaccine Sales Market Share by Application (2012-2017)
Figure United States Human Rotavirus Vaccine Sales Market Share by Application in 2016
Table United States Human Rotavirus Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Human Rotavirus Vaccine Sales Growth Rate by Application (2012-2017)
Table Merck & Co., Inc. Basic Information List
Table Merck & Co., Inc. Human Rotavirus Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Merck & Co., Inc. Human Rotavirus Vaccine Sales Growth Rate (2012-2017)
Figure Merck & Co., Inc. Human Rotavirus Vaccine Sales Market Share in United States (2012-2017)
Figure Merck & Co., Inc. Human Rotavirus Vaccine Revenue Market Share in United States (2012-2017)
Table Bharat Biotech Basic Information List
Table Bharat Biotech Human Rotavirus Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bharat Biotech Human Rotavirus Vaccine Sales Growth Rate (2012-2017)
Figure Bharat Biotech Human Rotavirus Vaccine Sales Market Share in United States (2012-2017)
Figure Bharat Biotech Human Rotavirus Vaccine Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline plc. Basic Information List
Table GlaxoSmithKline plc. Human Rotavirus Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure GlaxoSmithKline plc. Human Rotavirus Vaccine Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline plc. Human Rotavirus Vaccine Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline plc. Human Rotavirus Vaccine Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Rotavirus Vaccine
Figure Manufacturing Process Analysis of Human Rotavirus Vaccine
Figure Human Rotavirus Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Human Rotavirus Vaccine Major Players/Suppliers in 2016
Table Major Buyers of Human Rotavirus Vaccine
Table Distributors/Traders List
Figure United States Human Rotavirus Vaccine Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Human Rotavirus Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Human Rotavirus Vaccine Price (USD/MT) Trend Forecast (2017-2022)
Table United States Human Rotavirus Vaccine Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Human Rotavirus Vaccine Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Human Rotavirus Vaccine Sales Volume (K MT) Forecast by Type in 2022
Table United States Human Rotavirus Vaccine Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Human Rotavirus Vaccine Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Human Rotavirus Vaccine Sales Volume (K MT) Forecast by Application in 2022
Table United States Human Rotavirus Vaccine Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Human Rotavirus Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Human Rotavirus Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Human Rotavirus Vaccine Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources